A 35-year-old woman with a 5-year history of SLE on hydroxychloroquine and prednisolone presents with new-onset seizures and confusion. MRI brain shows no acute lesions. CSF analysis reveals elevated protein and normal glucose. Regarding CNS manifestations and immunological mechanisms in SLE, all of the following are recognized features EXCEPT:

Explanation

## CNS Manifestations of SLE — Immunopathology and Diagnostic Markers ### Recognized Mechanisms of Neuropsychiatric SLE **Key Point:** CNS-SLE involves multiple overlapping mechanisms: immune complex vasculitis, anti-neuronal antibodies (anti-NMDA, anti-RIPL), antiphospholipid antibody–mediated thrombosis, and cytokine-induced inflammation [cite:Harrison 21e Ch 312]. ### Anti-NMDA Receptor Antibodies **High-Yield:** Anti-NMDA receptor antibodies are present in 5–10% of SLE patients with neuropsychiatric manifestations and can cause: - Seizures - Psychosis - Movement disorders - Encephalitis They mediate disease via glutamate excitotoxicity and complement-dependent neuronal loss. This is a well-established pathogenic mechanism in CNS-SLE. ### Antiphospholipid Antibodies (aPL) in SLE **Clinical Pearl:** 30–40% of SLE patients have circulating aPL (anticardiolipin, anti-β~2~-glycoprotein I, lupus anticoagulant). aPL increase thrombotic risk (arterial and venous) and are a major cause of stroke in young SLE patients. They promote thrombosis via endothelial activation and platelet aggregation. ### Immune Complex Vasculitis in CNS-SLE **Key Point:** Immune complexes deposit in the choroid plexus, meninges, and cerebral vasculature, triggering: - Complement activation (C3/C4 depletion in CSF) - Vasculitis and blood–brain barrier disruption - Cytokine release (TNF-α, IL-6, IL-12) - Neuronal dysfunction and apoptosis ### CSF Findings in CNS-SLE — NOT Pathognomonic **Warning:** Elevated CSF IgG index and oligoclonal bands are **supportive** but **NOT pathognomonic** for CNS-SLE. These findings are also seen in: - Multiple sclerosis - Viral encephalitis - Neurosyphilis - Other autoimmune encephalitides | CSF Finding | Sensitivity in CNS-SLE | Specificity | Clinical Meaning | |-------------|------------------------|-------------|------------------| | **Elevated protein** | High (60–80%) | Low | Non-specific inflammation | | **Elevated IgG index** | Moderate (40–50%) | Low | Intrathecal Ig synthesis, but not diagnostic | | **Oligoclonal bands** | ~30% | Low | Suggests CNS inflammation, not SLE-specific | | **Anti-dsDNA in CSF** | Low (10–20%) | High | Rare, but highly specific if present | | **Low complement (C3/C4)** | Moderate | Moderate | Suggests active immune complex disease | **High-Yield:** Diagnosis of CNS-SLE is **clinical** (neuropsychiatric symptoms + active SLE serology + exclusion of other causes), NOT based on CSF oligoclonal bands alone. The absence of oligoclonal bands does NOT exclude CNS-SLE. ### Correct Answer Rationale Option 4 is **incorrect** because CSF IgG index and oligoclonal bands are neither sensitive nor specific for CNS-SLE. They are supportive findings but are also present in MS, viral encephalitis, and other conditions. They are **not pathognomonic** and cannot "definitively diagnose" CNS-SLE.